An alarming rise in the prevalence of heart valve diseases has contributed to reaching epidemic proportions of cardiovascular diseases, and by 2028, the adoption of heart valve repair and replacement products will reflect a ~US$ 12.6 billion market, opines a recent study published by Persistence Market Research (PMR). The report that studies growth parameters of the global market for heart valve repair and replacement also analyzes the important factors that are shaping the future demands and trends emerging in this landscape. The study finds that the need for heart valve repair and replacement remained highest for aortic valve stenosis in 2018. Being one of the most common yet most serious heart valve disease, high prevalence of aortic stenosis will continue to remain the primary driving factor for the global market for heart valve repair and replacement in the coming years, opines the PMR study. Though heart valve repair remains the first choice for medical professionals as well as patients, heart valve replacement is emerging as the most effective and an inevitable part of the treatment for aortic stenosis. The PMR study projects that aortic stenosis will account for nearly three-fourth revenue share of the heart valve and replacement market by 2028, and this underscores a prominent, emerging trend in this landscape. Adoption of Transcatheter Aortic Valve Implantation (TAVI) to Reach New Heights The PMR study finds that the need for TAVI remained higher than any other type of products used in heart valve repair and replacement surgeries in 2018, accounting for the largest share of the market value. The PMR study finds that the adoption of TAVI accounted for nearly US$ 3 billion in 2018, which reflects more than 67% of the revenue share in the heart valve repair and replacement market The study attributes medical professionals’ preferences as well as patients’ choice deviating from standard valve replacement procedures towards the ones that involve minimally invasive surgical techniques for the increasing need for TAVI in the heart valve repair and replacement market. Eventually, the role of TAVI in heart valve repair and replacement techniques has evolved from being merely an experimental technique to a highly reproducible procedure. Studies have found that the adoption of TAVI in the treatment for aortic stenosis, if compared with surgical aortic valve replacement, has helped medical professionals to reduce mortality rate significantly irrespective of baseline surgical complications and risks. Thereby, with the rise in the prevalence and incidence of aortic stenosis along with the patients’ tendency to prefer noninvasive medical procedures is contributing to the rise in the adoption of TAVI among intermediate risk patients with severe aortic stenosis. Request For Report Sample: https://www.persistencemarketresearch.com/samples/3192 With increasing awareness about the benefits of improving the quality of life for patients with TAVI over standard heart valve repair and replacement procedures will continue to foster this trend in the coming years. Taking into consideration the successful surgical outcomes with TAVI in treatment for various heart valve diseases, market players are expected to invest heavily in developing novel valve-in-valve procedures and gaining regulatory approvals to gain momentum in this landscape.